Biocon Limited has informed the Exchange regarding a press release dated September 26, 2024, titled "Biocon Limited partners with Tabuk Pharmaceuticals to commercialize its Glucagon-like peptide-1 (GLP -1) products in the Middle East region".
Biocon Limited has informed the Exchange regarding a press release dated September 26, 2024, titled "Biocon Limited partners with Tabuk Pharmaceuticals to commercialize its Glucagon-like peptide-1 (GLP -1) products in the Middle East region".